Yoga & naturopathy-based telemedicine as an adjuvant therapy in improving quality of life and alleviating anxiety and depression in mild to moderate COVID-19 positive patients

Phase 2

Active, not recruiting

Conditions: Coronavirus as the cause of diseases classified elsewhere,

Registration Number: CTRI/2021/05/033816

Lead Sponsor: Dr Pradeep MK Nair

Brief Summary: COVID-19 has induced a lot of distress across the nation. Medical fraternities of different disciplines are putting their best foot forward to combat this deadly virus. Yoga & Naturopathy is an evidence based system of medicine that can complement the conventional care in bringing better results. The outcome of this research will facilitate in helping many more patients across the globe that these interventions are beneficial. the patients will recieve either yoga and naturopathy based lifestyle modification or meditation in addition to the standard of care. We will be evaluating the changes in QOL and anxiety and depression along with symptom score in mild to moderate covid 19 positive patients who are in home quarantine.

Detailed Description: Not available

Recruitment & Eligibility

Status: Closed to Recruitment of Participants

Sex: All

Target Recruitment: 100

Inclusion Criteria

All positive mild and moderate COVID-19 cases who are receiving standard care and are in home quarantine.
Patients willing to consent to participate in the study.

Exclusion Criteria

All positive mild and moderate COVID-19 cases who are in hospital care Patients who require supplemental oxygen therapy Pregnant and lactating mothers Patients who are under 18 years of age.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in Anxiety and depression assessed by DASS 21 scale, improvement in QOL assessed by WHO-Bref, Improvement in symptoms	At baseline Baseline \| Anxiety and depression assessed by DASS 21 scale, Quality of Life assessed by WHO-BREF \| At 14th Day from baseline \| Anxiety and depression assessed by DASS 21 scale, Quality of Life assessed by WHO-BREF

Secondary Outcome Measures

Name	Time	Method
Improvement in symptoms	Baseline and daily till 14 days

Trial Locations

Locations (1): Sant Hirdaram Medical College of Naturopathy & Yogic Sciences for women, Bhopal
🇮🇳
Bhopal, MADHYA PRADESH, India
Sant Hirdaram Medical College of Naturopathy & Yogic Sciences for women, Bhopal
🇮🇳Bhopal, MADHYA PRADESH, India
Gulab Rai Tewani
Principal investigator
7000915602
drgulabtewani@gmail.com